GT
Galectin Therapeutics Inc
🇩🇪XSTU.PHPNGermanyHealthcare
€3.18EURunchanged 0.00 (0%)ClosedEnd of day10:38 PM
Price€3.180.00 (0%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US3632252025
- CUSIP
- Not reported
Company
- Employees
- 9
- Headquarters
- Norcross, United States
- CEO
- Mr. Joel Lewis CPA
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- 0.04%
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$27.84M+30.98%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$15.89M+55.39%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.